Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Ministry Of Health, Labour and Welfare in Japan Approves Partial Change to a New Drug Authorization for Moderna's Omicron-Targeting Bivalent Booster COVID-19 Vaccine, mRNA-1273.214: https://mms.businesswire.com/media/20210106005629/en/850492/5/KO_LOGO_%28002%29.jpg
Ministry Of Health, Labour and Welfare in Japan Approves Partial Change to a New Drug Authorization for Moderna's Omicron-Targeting Bivalent Booster COVID-19 Vaccine, mRNA-1273.214
Ministry Of Health, Labour and Welfare in Japan Approves Partial Change to a New Drug Authorization for Moderna's Omicron-Targeting Bivalent Booster COVID-19 Vaccine, mRNA-1273.214
DGAP-News: Moderna, Inc.: Moderna Reviews Clinical Trial Programs Across Portfolio at 2022 R&D Day: https://mms.businesswire.com/media/20210106005629/en/850492/5/KO_LOGO_%28002%29.jpg
DGAP-News: Moderna, Inc.: Moderna Reviews Clinical Trial Programs Across Portfolio at 2022 R&D Day
DGAP-News: Moderna, Inc.: Moderna Reviews Clinical Trial Programs Across Portfolio at 2022 R&D Day
DGAP-News: Gerresheimer AG: Gerresheimer AG and Stevanato Group announce Collaboration on the Development of an innovative Ready-To-Use Vial Platform for the Pharmaceutical Industry: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23715/Gerresheimer_logo.svg.png
DGAP-News: Gerresheimer AG: Gerresheimer AG and Stevanato Group announce Collaboration on the Development of an innovative Ready-To-Use Vial Platform for the Pharmaceutical Industry
DGAP-News: Gerresheimer AG: Gerresheimer AG and Stevanato Group announce Collaboration on the Development of an innovative Ready-To-Use Vial Platform for the Pharmaceutical Industry
DGAP-News: ENCAVIS AG has been promoted to the STOXX Europe 600: https://upload.wikimedia.org/wikipedia/commons/thumb/4/44/Encavis_logo.svg/1024px-Encavis_logo.svg.png
DGAP-News: ENCAVIS AG has been promoted to the STOXX Europe 600
DGAP-News: ENCAVIS AG has been promoted to the STOXX Europe 600
DGAP-News: SHOP APOTHEKE EUROPE READY FOR THE NEXT PHASE OF E-PRESCRIPTIONS IN GERMANY.: https://upload.wikimedia.org/wikipedia/commons/thumb/0/07/Shop_Apotheke_Europe_logo.svg/640px-Shop_Apotheke_Europe_logo.svg.png
DGAP-News: SHOP APOTHEKE EUROPE READY FOR THE NEXT PHASE OF E-PRESCRIPTIONS IN GERMANY.
DGAP-News: SHOP APOTHEKE EUROPE READY FOR THE NEXT PHASE OF E-PRESCRIPTIONS IN GERMANY.
DGAP-News: GEA invests EUR 70 million in pharma technology center in Germany: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23714/375px-GEA_Group_2010_logo.svg.png
DGAP-News: GEA invests EUR 70 million in pharma technology center in Germany
DGAP-News: GEA invests EUR 70 million in pharma technology center in Germany
DGAP-News: Stabilus SE completes relocation of its registered office to Germany: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24125/375px-Stabilus_logo.svg.png
DGAP-News: Stabilus SE completes relocation of its registered office to Germany
DGAP-News: Stabilus SE completes relocation of its registered office to Germany
Semtech Announces 20th BlueRiver® Collaboration with ProITAV: https://mms.businesswire.com/media/20220901005297/en/1559137/5/blueriver_proitav_press.jpg
Semtech Announces 20th BlueRiver® Collaboration with ProITAV


Semtech Corporation (Nasdaq: SMTC), a leading global supplier of high performance analog and mixed-signal semiconductors and advanced algorithms, announced its 20th collaboration with global

DGAP-News: EMA Committee for Medicinal Products for Human Use (CHMP) Adopts Positive Opinion Recommending Authorization for the Use of Moderna's Omicron-Targeting Bivalent Booster in the European Union: https://mms.businesswire.com/media/20210106005629/en/850492/5/KO_LOGO_%28002%29.jpg
DGAP-News: EMA Committee for Medicinal Products for Human Use (CHMP) Adopts Positive Opinion Recommending Authorization for the Use of Moderna's Omicron-Targeting Bivalent Booster in the European Union
DGAP-News: EMA Committee for Medicinal Products for Human Use (CHMP) Adopts Positive Opinion Recommending Authorization for the Use of Moderna's Omicron-Targeting Bivalent Booster in the European Union
TUI AG: Director Declaration: https://upload.wikimedia.org/wikipedia/commons/1/1c/TUI_Logo_neu.png
TUI AG: Director Declaration
TUI AG: Director Declaration
DGAP-News: Nemetschek Group appoints new Chief Division Officer for Operate & Manage and Digital Twin: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24062/Nemetschek_AG_Logo.svg.png
DGAP-News: Nemetschek Group appoints new Chief Division Officer for Operate & Manage and Digital Twin
DGAP-News: Nemetschek Group appoints new Chief Division Officer for Operate & Manage and Digital Twin
DGAP-News: Nemetschek Group appoints new Chief Division Officer for Operate & Manage and Digital Twin: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24062/Nemetschek_AG_Logo.svg.png
DGAP-News: Nemetschek Group appoints new Chief Division Officer for Operate & Manage and Digital Twin
DGAP-News: Nemetschek Group appoints new Chief Division Officer for Operate & Manage and Digital Twin
DGAP-News: MorphoSys appoints Tim Demuth as new Chief Research and Development Officer, following the retirement of Malte Peters: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
DGAP-News: MorphoSys appoints Tim Demuth as new Chief Research and Development Officer, following the retirement of Malte Peters
DGAP-News: MorphoSys appoints Tim Demuth as new Chief Research and Development Officer, following the retirement of Malte Peters
DGAP-News: MorphoSys appoints Tim Demuth as new Chief Research and Development Officer, following the retirement of Malte Peters: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
DGAP-News: MorphoSys appoints Tim Demuth as new Chief Research and Development Officer, following the retirement of Malte Peters
DGAP-News: MorphoSys appoints Tim Demuth as new Chief Research and Development Officer, following the retirement of Malte Peters
Midea gibt die Halbjahresergebnisse für 2022 bekannt: Stetiges Umsatz- und Gewinnwachstum, Beschleunigung der technologiegetriebenen Transformation: https://mms.businesswire.com/media/20220830006041/de/1557904/5/907efc8e4c67115d7cac6bc813dd522.jpg
Midea gibt die Halbjahresergebnisse für 2022 bekannt: Stetiges Umsatz- und Gewinnwachstum, Beschleunigung der technologiegetriebenen Transformation


Midea hat seinen Finanzbericht für das erste Halbjahr 2022 veröffentlicht, der ein Umsatzwachstum von 5,0 % auf 183,7 Mrd. RMB ausweist. Der Nettogewinn wuchs sogar noch schneller als der Umsatz

Midea Announces 2022 Semi-annual Results: Steady Growth in Revenue and Profit, Acceleration in Technology-driven Transformation: https://mms.businesswire.com/media/20220830006040/en/1557904/5/907efc8e4c67115d7cac6bc813dd522.jpg
Midea Announces 2022 Semi-annual Results: Steady Growth in Revenue and Profit, Acceleration in Technology-driven Transformation


Midea released its financial report for the first half of 2022, showing semi-annual revenue growth from 5.0% to RMB183.7bn. Net profit growth was even faster than revenue, coming in at RMB 16bn

DGAP-News: 125 Young People Embark on Careers with the KION Group : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23724/Kion_Group_logo.svg.png
DGAP-News: 125 Young People Embark on Careers with the KION Group
DGAP-News: 125 Young People Embark on Careers with the KION Group
DGAP-News: Moderna, Inc.: Swissmedic Authorizes Moderna’s Omicron-Targeting Bivalent Booster Candidate, MRNA-1273.214: https://mms.businesswire.com/media/20210106005629/en/850492/5/KO_LOGO_%28002%29.jpg
DGAP-News: Moderna, Inc.: Swissmedic Authorizes Moderna’s Omicron-Targeting Bivalent Booster Candidate, MRNA-1273.214
DGAP-News: Moderna, Inc.: Swissmedic Authorizes Moderna’s Omicron-Targeting Bivalent Booster Candidate, MRNA-1273.214
DGAP-News: Evotec expands clinical and commercial drug substance manufacturing with acquisition of Central Glass Germany: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
DGAP-News: Evotec expands clinical and commercial drug substance manufacturing with acquisition of Central Glass Germany
DGAP-News: Evotec expands clinical and commercial drug substance manufacturing with acquisition of Central Glass Germany
Power Integrations Delivers AEC-Qualified Buck Switcher IC with 850 mA Output for Low-Part-Count Automotive PSUs
Power Integrations Delivers AEC-Qualified Buck Switcher IC with 850 mA Output for Low-Part-Count Automotive PSUs


Power Integrations (NASDAQ: POWI), the leader in high-voltage integrated circuits for energy-efficient power conversion, today announced a high-current member of its LinkSwitch™-TN2Q automotive

Semtech Introduces CopperEdge™ 112G PAM4 Product Portfolio for 400G and 800G Data Center Applications
Semtech Introduces CopperEdge™ 112G PAM4 Product Portfolio for 400G and 800G Data Center Applications


Semtech Corporation (Nasdaq: SMTC), a leading global supplier of high performance analog and mixed-signal semiconductors and advanced algorithms, announced the launch of the new CopperEdge™ product

DGAP-News: ENCAVIS AG acquires a ready-to-build 26 MWp solar park in Hockliffe for the strategic expansion of the PPA solar park portfolio in the UK: https://upload.wikimedia.org/wikipedia/commons/thumb/4/44/Encavis_logo.svg/1024px-Encavis_logo.svg.png
DGAP-News: ENCAVIS AG acquires a ready-to-build 26 MWp solar park in Hockliffe for the strategic expansion of the PPA solar park portfolio in the UK
DGAP-News: ENCAVIS AG acquires a ready-to-build 26 MWp solar park in Hockliffe for the strategic expansion of the PPA solar park portfolio in the UK
DGAP-News: TAG Immobilien AG: Strong operating business performance in the second quarter of 2022 for TAG Immobilien AG across all metrics. LTV reduced below 45% through capital increase in July 2022: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23744/TAG_Immobilien_logo.svg.png
DGAP-News: TAG Immobilien AG: Strong operating business performance in the second quarter of 2022 for TAG Immobilien AG across all metrics. LTV reduced below 45% through capital increase in July 2022
DGAP-News: TAG Immobilien AG: Strong operating business performance in the second quarter of 2022 for TAG Immobilien AG across all metrics. LTV reduced below 45% through capital increase in July 2022
DGAP-News: ENCAVIS AG is expanding its solar park portfolio in the Netherlands by 48 megawatts: https://upload.wikimedia.org/wikipedia/commons/thumb/4/44/Encavis_logo.svg/1024px-Encavis_logo.svg.png
DGAP-News: ENCAVIS AG is expanding its solar park portfolio in the Netherlands by 48 megawatts
DGAP-News: ENCAVIS AG is expanding its solar park portfolio in the Netherlands by 48 megawatts
Semtech’s LoRa® Devices and LoRaWAN® Standard Integrated Into IoT Ventures and Lacuna Space Water Monitoring System
Semtech’s LoRa® Devices and LoRaWAN® Standard Integrated Into IoT Ventures and Lacuna Space Water Monitoring System


Semtech Corporation (Nasdaq: SMTC), a leading global supplier of high performance analog and mixed-signal semiconductors and advanced algorithms, announced a collaboration with New Zealand’s IoT